Sugi Predict

Sugi Predict / Compounds / SCHEMBL696271

SCHEMBL696271

SCHEMBL696271

O=C(O)C1(C(F)(F)F)CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 1/20 0.41
▸ CYP2C19 P33261 1/20 0.38
▸ RIPK1 Q13546 2/20 0.33
▸ AKR1C1 Q04828 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ CACNA2D1 P54289 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ CPB2 Q96IY4 5/20 0.31
▸ FFAR3 O14843 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL12479454 0.98 DGAT1 (0.40) DGAT1CYP2C19RIPK1AKR1C1USP2
SCHEMBL1786525 0.97 DGAT1 (0.43) DGAT1CYP2C19RIPK1AKR1C1FFAR3
SCHEMBL17586 0.92 DGAT1 (0.43) DGAT1CYP2C19RIPK1FFAR3
SCHEMBL18559 0.87 DGAT1 (0.52) DGAT1FFAR3
Hydrochloric Acid SCHEMBL23094114 0.84 DGAT1 (0.50) DGAT1FFAR3
SCHEMBL9446531 0.82 DGAT1 (0.43) DGAT1CYP2C19RIPK1
SCHEMBL9694952 0.80 DGAT1 (0.41) DGAT1RIPK1
SCHEMBL28167619 0.79 DGAT1 (0.44) DGAT1RIPK1
SCHEMBL4028374 0.78 DGAT1 (0.40) DGAT1RIPK1
SCHEMBL2405619 0.78 DGAT1 (0.45) DGAT1CYP2C19RIPK1USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6383274-B1 Ink jet ink compositions and printing processes XEROX CORPORATION 2002-05-07 — — US claimed
JP-4013645-A — — None — — JP disclosed
US-12492182-B2 Hydroxytriazine compounds and pharmaceutical use thereof JAPAN TOBACCO INC. (JP) 2025-12-09 — — US disclosed
EP-4642782-A2 ALPHA-V-BETA-8 INTEGRIN INHIBITORS AND USES THEREOF Pliant Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
US-20250313574-A1 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME EISAI R&D MANAGEMENT CO., LTD. (JP) 2025-10-09 — — US disclosed
EP-4605409-A2 CYCLIN INHIBITORS Circle Pharma, Inc. (US) 2025-08-27 — — EP disclosed
EP-4536653-A2 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME Eisai R&D Management Co., Ltd. (JP) 2025-04-16 — — EP disclosed
US-20240245682-A1 ALPHA-V-BETA-8 INTEGRIN INHIBITORS AND USES THEREOF PLIANT THERAPEUTICS, INC. 2024-07-25 — — US disclosed
WO-2024145245-A2 ALPHA-V-BETA-8 INTEGRIN INHIBITORS AND USES THEREOF PLIANT THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
US-20240218021-A1 CYCLIN INHIBITORS CIRCLE PHARMA, INC. 2024-07-04 — — US disclosed
US-20080188689-A1 Preparation of organic compounds bearing a trifluoromethyl group on a quaternary carbon VERSUM MATERIALS US, LLC 2008-08-07 — — US disclosed
WO-2008066664-A2 CIS-CYCLOHEXYL SUBSTITUTED PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2008-06-05 — — WO disclosed
WO-2008059042-A1 2-CARBOXY THIOPHENE DERIVATIVES AS ANTI VIRAL AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2008-05-22 — — WO disclosed
CN-1102568-C Pesticidal compounds BRITISH TECH GROUP (GB) 2003-03-05 — — CN disclosed
US-6383274-B1 Ink jet ink compositions and printing processes XEROX CORPORATION 2002-05-07 — — US disclosed
US-5962002-A 1,1,4,4-SUBSTITUTED DIHYDRONAPHTHALENE COMPOUNDS BTG INTERNATIONAL LIMITED (GB) 1999-10-05 — — US disclosed
EP-0802730-B1 PESTICIDAL COMPOUNDS BTG INT LTD (GB) 1999-06-23 — — EP disclosed
EP-0802730-A1 PESTICIDAL COMPOUNDS BTG INTERNATIONAL LIMITED (GB) 1997-10-29 — — EP disclosed
WO-1996021355-A1 PESTICIDAL COMPOUNDS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1996-07-18 — — WO disclosed
JP-H0413645-A OPTICALLY ACTIVE TRIFLUOROMETHYLCYCLOHEXANECAREBOXYLIC ACID, PRODUCTION THEREOF AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME YAMAKAWA YAKUHIN KOGYO KK 1992-01-17 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240245682-A1 ALPHA-V-BETA-8 INTEGRIN INHIBITORS AND USES THEREOF ITGB8, ITGAV, ITGA8 DGAT1 2387/4885CYP2C19 4418/4885RIPK1 1108/4885
US-20080188689-A1 Preparation of organic compounds bearing a trifluoromethyl group on a quaternary carbon AFF4, RFC4, SF3B3 DGAT1 3404/4885CYP2C19 1162/4885RIPK1 3206/4885
US-20250313574-A1 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME NEU1, NEU2, NEU4 DGAT1 1928/4885CYP2C19 2048/4885RIPK1 3297/4885
US-20240218021-A1 CYCLIN INHIBITORS CCNI, CCNC, CDK2 DGAT1 3219/4885CYP2C19 2043/4885RIPK1 2867/4885
US-12492182-B2 Hydroxytriazine compounds and pharmaceutical use thereof PTGS1, PTGIS, PTGES DGAT1 1971/4885CYP2C19 2002/4885RIPK1 2493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.